TFOS DEWS II Report Executive Summary

Jennifer P Craig¹, J Daniel Nelson², Dimitri T Azar³, Carlos Belmonte⁴, Anthony J Bron⁵, Sunil K Chauhan⁶, Cintia S de Paiva⁷, José A P Gomes⁸, Katherine M Hammitt⁹, Lyndon Jones¹⁰, Jason J Nichols¹¹, Kelly K Nichols¹¹, Gary D Novack¹², Fiona J Stapleton¹³, Mark D P Willcox¹³, James S Wolffsohn¹⁴, David A Sullivan¹⁵

Affiliations

¹ Department of Ophthalmology, New Zealand National Eye Centre, The University of Auckland, Auckland, New Zealand.
² Department of Ophthalmology, HealthPartners Medical Group and Clinics, St Paul, MN, USA; Department of Ophthalmology, University of Minnesota, Minneapolis, USA.
³ University of Illinois at Chicago College of Medicine, Chicago, IL, USA.
⁴ Instituto de Neurociencias de Alicante, University Miguel Hernandez-CSIC, Spain; Instituto Fernandez-Vega, Oviedo University, Spain.
⁵ Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Vision and Eye Research Unit, Anglia Ruskin University, Cambridge, UK.
⁶ Schepens Eye Research Institute, Massachusetts Eye and Ear, and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
⁷ Department of Ophthalmology, Baylor College of Medicine, Houston, TX, USA.
⁸ Department of Ophthalmology and Visual Sciences, Federal University of Sao Paulo/Paulista School of Medicine, Sao Paulo, Brazil.
⁹ Sjögren's Syndrome Foundation, Bethesda, MD, USA.
¹⁰ Centre for Contact Lens Research, School of Optometry and Vision Science, University of Waterloo, Waterloo, Ontario, Canada.
¹¹ University of Alabama at Birmingham School of Optometry, Birmingham, AL, USA.
¹² Pharma Logic Development, San Rafael, CA, USA; Departments of Pharmacology and Ophthalmology, University of California, Davis, School of Medicine, USA.
¹³ School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.
¹⁴ School of Life and Health Sciences, Aston University, Birmingham, UK.
¹⁵ Schepens Eye Research Institute, Massachusetts Eye and Ear, and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. Electronic address: david.sullivan@schepens.harvard.edu.

PMID: 28797892
DOI: 10.1016/j.jtos.2017.08.003

Review

TFOS DEWS II Report Executive Summary

Jennifer P Craig et al. Ocul Surf. 2017 Oct.

. 2017 Oct;15(4):802-812.

doi: 10.1016/j.jtos.2017.08.003. Epub 2017 Aug 8.

Authors

Affiliations

¹ Department of Ophthalmology, New Zealand National Eye Centre, The University of Auckland, Auckland, New Zealand.
² Department of Ophthalmology, HealthPartners Medical Group and Clinics, St Paul, MN, USA; Department of Ophthalmology, University of Minnesota, Minneapolis, USA.
³ University of Illinois at Chicago College of Medicine, Chicago, IL, USA.
⁴ Instituto de Neurociencias de Alicante, University Miguel Hernandez-CSIC, Spain; Instituto Fernandez-Vega, Oviedo University, Spain.
⁵ Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Vision and Eye Research Unit, Anglia Ruskin University, Cambridge, UK.
⁶ Schepens Eye Research Institute, Massachusetts Eye and Ear, and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
⁷ Department of Ophthalmology, Baylor College of Medicine, Houston, TX, USA.
⁸ Department of Ophthalmology and Visual Sciences, Federal University of Sao Paulo/Paulista School of Medicine, Sao Paulo, Brazil.
⁹ Sjögren's Syndrome Foundation, Bethesda, MD, USA.
¹⁰ Centre for Contact Lens Research, School of Optometry and Vision Science, University of Waterloo, Waterloo, Ontario, Canada.
¹¹ University of Alabama at Birmingham School of Optometry, Birmingham, AL, USA.
¹² Pharma Logic Development, San Rafael, CA, USA; Departments of Pharmacology and Ophthalmology, University of California, Davis, School of Medicine, USA.
¹³ School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.
¹⁴ School of Life and Health Sciences, Aston University, Birmingham, UK.
¹⁵ Schepens Eye Research Institute, Massachusetts Eye and Ear, and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. Electronic address: david.sullivan@schepens.harvard.edu.

PMID: 28797892
DOI: 10.1016/j.jtos.2017.08.003

Abstract

This article presents an Executive Summary of the conclusions and recommendations of the 10-chapter TFOS DEWS II report. The entire TFOS DEWS II report was published in the July 2017 issue of The Ocular Surface. A downloadable version of the document and additional material, including videos of diagnostic and management techniques, are available on the TFOS website: www.TearFilm.org.

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

TFOS DEWS II Report Executive Summary

Affiliations

TFOS DEWS II Report Executive Summary

Authors

Affiliations

Abstract

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical